Figure 2 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

Figure 2 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

<p>Percentage change in Ki67 between pretreatment (baseline) and surgery for part 1 (<b>A</b>) and part 2 (<b>B</b>); Kaplan–Meier estimates by treatment group for relapse free survival (<b>C</b>) and overall survival (<b>D</b>). <b>A,</...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: Nigel Bundred (15046233) (author)
Další autoři: Nuria Porta (15029895) (author), Adrian Murray Brunt (15046236) (author), Angela Cramer (5870894) (author), Andrew Hanby (25460) (author), Abeer M. Shaaban (15046239) (author), Emad A. Rakha (7957955) (author), Anne Armstrong (15045410) (author), Ramsey I. Cutress (15046242) (author), David Dodwell (15046245) (author), Marie A. Emson (15046248) (author), Abigail Evans (7421527) (author), Sue M. Hartup (15046251) (author), Kieran Horgan (15030513) (author), Sarah E. Miller (15046254) (author), Stuart A. McIntosh (11368948) (author), James P. Morden (7594370) (author), Jay Naik (15046257) (author), Sankaran Narayanan (15046260) (author), Jane Ooi (15046263) (author), Anthony I. Skene (15046266) (author), David A. Cameron (6277425) (author), Judith M. Bliss (8827107) (author)
Vydáno: 2025
Témata:
Cancer
Cancer Detection and Diagnosis
Clinical Research and Trials
Biomarkers
Prognostic biomarkers
Breast Cancer
Clinical Trial Results
Phase II clinical trials
Precision Medicine
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky